Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J Webb

Showing results (211-220 of 360) with videos related to

Pageof 36
Sort By:
Heart (British Cardiac Society)|September 22, 1999
Early therapeutic experience with the endothelin antagonist BQ-123 in pulmonary hypertension after congenital heart surgeryB Prendergast, D E Newby, L E Wilson, et al.
Scottish Medical Journal|September 19, 2007
Scottish Medicines Consortium: an overview of rapid new drug assessment in ScotlandJ Dear, C O'Dowd, A Timoney, et al.
Cardiovascular Research|February 17, 1998
Endogenous angiotensin II contributes to basal peripheral vascular tone in sodium deplete but not sodium replete manD E Newby, S Masumori, N R Johnston, et al.
The Journal of Biological Chemistry|May 28, 1998
Localization of the binding site for transforming growth factor-beta in human alpha2-macroglobulin to a 20-kDa peptide that also contains the bait regionD J Webb, J Wen, L R Karns, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|December 1, 1988
Sympathetically mediated vasoconstriction is augmented by angiotensin II in manD J Webb, P H Seidelin, N Benjamin, et al.
British Journal of Pharmacology|September 1, 1996
The increase in human plasma immunoreactive endothelin but not big endothelin-1 or its C-terminal fragment induced by systemic administration of the endothelin antagonist TAK-044C Plumpton, C J Ferro, W G Haynes, et al.
Clinical Pharmacology and Therapeutics|August 17, 2000
Big endothelin-3 constricts forearm resistance vessels but not hand veins in humansC J Ferro, F E Strachan, E Shepherd, et al.
Biochemical and Biophysical Research Communications|December 19, 2000
Inhibition of human platelet aggregation by nitric oxide donor drugs: relative contribution of cGMP-independent mechanismsN Sogo, K S Magid, C A Shaw, et al.
Circulation|October 31, 2001
Bradykinin contributes to the vasodilator effects of chronic angiotensin-converting enzyme inhibition in patients with heart failureF N Witherow, A Helmy, D J Webb, et al.
The Journal of Clinical Endocrinology and Metabolism|December 17, 1997
Seasonal variation in glucocorticoid activity in healthy menB R Walker, R Best, J P Noon, et al.
Pageof 36

Showing results (211-220 of 360) with videos related to

Sort By:
Pageof 36
Heart (British Cardiac Society)|September 22, 1999
Early therapeutic experience with the endothelin antagonist BQ-123 in pulmonary hypertension after congenital heart surgeryB Prendergast, D E Newby, L E Wilson, et al.
Scottish Medical Journal|September 19, 2007
Scottish Medicines Consortium: an overview of rapid new drug assessment in ScotlandJ Dear, C O'Dowd, A Timoney, et al.
Cardiovascular Research|February 17, 1998
Endogenous angiotensin II contributes to basal peripheral vascular tone in sodium deplete but not sodium replete manD E Newby, S Masumori, N R Johnston, et al.
The Journal of Biological Chemistry|May 28, 1998
Localization of the binding site for transforming growth factor-beta in human alpha2-macroglobulin to a 20-kDa peptide that also contains the bait regionD J Webb, J Wen, L R Karns, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|December 1, 1988
Sympathetically mediated vasoconstriction is augmented by angiotensin II in manD J Webb, P H Seidelin, N Benjamin, et al.
British Journal of Pharmacology|September 1, 1996
The increase in human plasma immunoreactive endothelin but not big endothelin-1 or its C-terminal fragment induced by systemic administration of the endothelin antagonist TAK-044C Plumpton, C J Ferro, W G Haynes, et al.
Clinical Pharmacology and Therapeutics|August 17, 2000
Big endothelin-3 constricts forearm resistance vessels but not hand veins in humansC J Ferro, F E Strachan, E Shepherd, et al.
Biochemical and Biophysical Research Communications|December 19, 2000
Inhibition of human platelet aggregation by nitric oxide donor drugs: relative contribution of cGMP-independent mechanismsN Sogo, K S Magid, C A Shaw, et al.
Circulation|October 31, 2001
Bradykinin contributes to the vasodilator effects of chronic angiotensin-converting enzyme inhibition in patients with heart failureF N Witherow, A Helmy, D J Webb, et al.
The Journal of Clinical Endocrinology and Metabolism|December 17, 1997
Seasonal variation in glucocorticoid activity in healthy menB R Walker, R Best, J P Noon, et al.
Pageof 36